Secondary sclerosing cholangitis
Secondary sclerosing cholangitis (SSC) is a chronic liver disease that results from the progressive inflammation and scarring of the bile ducts within the liver. This condition is termed "secondary" as it occurs due to an identifiable cause or condition, unlike primary sclerosing cholangitis (PSC), which has no known cause.
Etiology
The exact cause of SSC is not fully understood, but it is known to be associated with several conditions such as ischemia, sepsis, trauma, and immunodeficiency. It can also occur as a complication of surgical procedures or due to the use of certain medications.
Pathophysiology
In SSC, the inflammation and scarring of the bile ducts lead to their narrowing and obstruction. This results in the accumulation of bile in the liver, causing further inflammation and eventually leading to cirrhosis and liver failure.
Clinical Presentation
Patients with SSC often present with symptoms such as jaundice, pruritus, and fatigue. They may also have signs of advanced liver disease such as ascites, hepatic encephalopathy, and variceal bleeding.
Diagnosis
The diagnosis of SSC is typically made based on a combination of clinical features, laboratory findings, imaging studies, and sometimes, liver biopsy. The presence of cholangiographic abnormalities such as multifocal strictures and dilatations in the bile ducts is a key diagnostic feature.
Treatment
The treatment of SSC is primarily aimed at managing the symptoms and slowing the progression of the disease. This may involve the use of medications to reduce inflammation and improve bile flow, endoscopic procedures to relieve bile duct obstruction, and in severe cases, liver transplantation.
Prognosis
The prognosis of SSC varies widely and depends on several factors including the underlying cause, the extent of liver damage, and the patient's overall health status.
See Also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
